Navigation Links
New technique measures ultrashort laser pulses at focus
Date:5/9/2008

n, a graduate student supported by the Technological Innovation: Generating Economic Results (TI:GER) program.

To achieve the highest possible intensity of the laser, the pulse must be as small as possible in space and as short as possible in time. However, focused pulses nearly always have distortions in time that vary significantly from point to point in space due to lens aberrations in focusing optics.

To address those issues, the new device, called SEA TADPOLE (Spatial Encoded Arrangement for Temporal Analysis by Dispersing a Pair of Light E-fields), allows researchers to measure complicated ultrashort pulses simultaneously in space and time as they go through the focus.

A lot of chemists and biologists use ultrafast lasers, so it was important that our device be easy to use because non-laser scientists dont want to spend all day measuring their laser pulses, noted Bowlan.

The research team which also included former graduate students Pablo Gabolde and Selcuk Akturk used the concept of interferometry to measure a pulse in space and time. Two pulses, one reference and one unknown, were sent through optical fibers. The fibers were mounted on a scanning stage so that the pulses could be measured at many locations around the focus.

The pulses were crossed and an interference pattern was recorded for each color of the pulse at each location with a digital camera. The patterns were used to determine the shape of the unknown pulse in space and time and to create movies showing how the intensity and color of the pulse changed in space and time as it focused.

Because the laser pulses enter SEA TADPOLE through optical fibers, which only collect a very small portion of the light, the device naturally measures pulses with high spatial resolution and can measure them at a focus spot size smaller than a micron, explained Bowlan. To further improve the spatial resolution of the device, the research team began to use s
'/>"/>

Contact: Abby Vogel
avogel@gatech.edu
404-385-3364
Georgia Institute of Technology Research News
Source:Eurekalert  

0

GOOD

Page: 1 2 3

Related biology technology :

1. White Paper Details New Techniques for Isolating, Identifying Anaerobic Bacteria and Organisms
2. Assembly technique for tiny wires may eventually help detect cancer and other diseases
3. Unique infrared technique finds applications in nanoscience
4. DNA technique yields 3-D crystalline organization of nanoparticles
5. Cardica and Intuitive Surgical to Host Educational Symposium on Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair
6. Doping technique brings nanomechanical devices into the semiconductor world
7. Glycominds Joins Biomolecular Photonic (BMP) Consortium to Develop New Molecular Imaging Technique
8. University of Leicester scientists discover technique to help friendly bacteria
9. New technique can be breakthrough for early cancer diagnosis
10. NIH Announces Advanced Cell Technologys Single Cell Embryo Biopsy Technique as a Means to Derive Embryonic Stem Cells to be Considered for Federal Funding
11. New DNA-based technique for assembly of nano- and micro-sized particles
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New technique measures ultrashort laser pulses at focus
New technique measures ultrashort laser pulses at focus
Breaking Biology Technology:YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 2Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4
Other Biology Technology:Alexion's Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product 2Alexion's Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product 3Alexion's Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product 4Alexion's Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product 5China Sky One Medical, Inc. Raises Guidance for 2008 Revenue and Net Income 2China Sky One Medical, Inc. Raises Guidance for 2008 Revenue and Net Income 3Napo Pharmaceuticals Will Provide Pediatric Formulation of Crofelemer at Cost to Developing Nations to Help Treat Life-Threatening Diarrhoel Diseases (Subject to FDA Approval) 2Napo Pharmaceuticals Will Provide Pediatric Formulation of Crofelemer at Cost to Developing Nations to Help Treat Life-Threatening Diarrhoel Diseases (Subject to FDA Approval) 3Napo Pharmaceuticals Will Provide Pediatric Formulation of Crofelemer at Cost to Developing Nations to Help Treat Life-Threatening Diarrhoel Diseases (Subject to FDA Approval) 4Napo Pharmaceuticals Will Provide Pediatric Formulation of Crofelemer at Cost to Developing Nations to Help Treat Life-Threatening Diarrhoel Diseases (Subject to FDA Approval) 5
Breaking Biology News(10 mins): Killer catfish? Venomous species surprisingly common, study finds 2Climate projections underestimate CO2 impact 2University of Texas Southwestern Medical Center researcher wins Avanti Award in lipids 2New National Poll Finds Americans Strongly Opposed to Cutting Medicare Payments for Nursing Home Care as a Means of Financing Health Care Reform 55742 1New National Poll Finds Americans Strongly Opposed to Cutting Medicare Payments for Nursing Home Care as a Means of Financing Health Care Reform 55742 2New National Poll Finds Americans Strongly Opposed to Cutting Medicare Payments for Nursing Home Care as a Means of Financing Health Care Reform 55742 3New National Poll Finds Americans Strongly Opposed to Cutting Medicare Payments for Nursing Home Care as a Means of Financing Health Care Reform 55742 4Noteworthy Medical Systems Demonstrates National Health Information Network 28NHIN 29 Interoperability 55739 1Noteworthy Medical Systems Demonstrates National Health Information Network 28NHIN 29 Interoperability 55739 2Noteworthy Medical Systems Demonstrates National Health Information Network 28NHIN 29 Interoperability 55739 3Do Good When You Shop and Help Educate a Generation of Healthy Kids 55736 1Do Good When You Shop and Help Educate a Generation of Healthy Kids 55736 2